CMS expanded the master list of DMEPOS items requiring prior authorization in 2026, and the practical effect runs through both the DME supplier industry and the prescribing practice side. The Medicare prior authorization process for DMEPOS items now applies to more than 100 specific items across power mobility devices, certain support surfaces, lower limb prosthetics, and selected orthotic codes. Suppliers must obtain affirmative prior authorization before delivering covered items, or the claim will deny. Prescribing physicians need to provide documentation that meets the medical necessity criteria, on the supplier’s timeline. The bottleneck is the documentation handoff between practice and supplier, and 2026 is the year practices that have not built it will absorb avoidable denials.
What is on the expanded list
The 2026 expansion includes items that have been historically high-error categories in CMS Comprehensive Error Rate Testing data. Power wheelchairs and power mobility devices remain on the list. Pressure-reducing support surfaces (E0277, E0193, E0371, E0372, E0373) have been added or expanded. Selected lower limb prosthetics, including L5856, L5857, and L5858 microprocessor-controlled knees, are included. Certain orthotic codes for back braces and knee orthotics have been added. The full list is published in the CMS DMEPOS prior authorization program documentation, and practices that prescribe in any of these categories should verify whether their commonly ordered items have moved into prior authorization.
The supplier-prescriber handoff
The Medicare DMEPOS prior authorization process is initiated by the supplier, not the prescriber. The supplier submits the prior authorization request to the DME Medicare Administrative Contractor, including the prescription, the medical necessity documentation, and any required certificates of medical necessity. The decision returns within 10 business days for most categories. The bottleneck is documentation. Suppliers cannot submit a complete prior authorization without documentation from the prescribing practice, and practices that respond slowly to documentation requests delay the patient’s access to the device and create operational friction.
Documentation that supports the request
Each DMEPOS category has specific medical necessity requirements published as Local Coverage Determinations or National Coverage Determinations. For power mobility devices, the documentation must establish that the patient’s mobility limitation prevents independent participation in mobility-related activities of daily living, that other less costly alternatives have been considered, and that the patient has the cognitive and physical ability to use the device safely. For pressure-reducing surfaces, documentation must establish the patient’s risk of pressure ulcer (using a validated risk assessment tool) and the failure or unsuitability of less costly alternatives. For lower limb prosthetics, documentation must establish the functional level (K0 through K4) and the rehabilitation potential. Practices that maintain templated documentation aligned to each category’s LCD speed the prior auth process meaningfully.
The face-to-face requirement
Most DMEPOS items requiring prior authorization also require a face-to-face encounter between the prescribing physician (or qualified non-physician practitioner) and the patient within the six months before the prescription. The encounter must specifically address the medical condition supporting the need for the equipment, and the documentation must reflect that. Phone-only encounters and telehealth encounters that meet the standard for direct supervision and that occur within the six-month window typically qualify, although requirements vary by category. The face-to-face documentation must be in the patient’s medical record, accessible to the supplier on request.
Denials and resubmission
A non-affirmative prior authorization decision (the equivalent of a denial) leaves the supplier with two paths: appeal the prior auth decision through the Medicare appeals process, or resubmit with additional documentation. Resubmission is often faster when the documentation gap is clear (missing risk assessment, incomplete face-to-face documentation, missing functional level for prosthetics). Suppliers that build a quick-turn resubmission workflow with prescribing practices recover meaningful volume. Suppliers and practices that treat each non-affirmative as a final answer leave volume unrecovered.
Practice-side workflow that supports suppliers
Practices that prescribe DMEPOS items frequently can reduce friction with suppliers and speed patient access by maintaining LCD-aligned documentation templates for the categories they prescribe most often, designating a single point of contact for supplier documentation requests, responding to documentation requests within 48 hours, and tracking prior authorization status as part of routine follow-up workflow. Patients whose prior auth process stalls because of practice-side delays often switch suppliers, which fragments care continuity and creates bad-debt risk on services already rendered.
How MHB helps practices and suppliers
For practices and DMEPOS suppliers that want a faster handoff process with LCD-aligned documentation, prior authorization tracking, and resubmission workflow, our team supports insurance verification and prior authorization for DMEPOS with category-specific medical necessity workflows.
The bottom line
The 2026 DMEPOS prior authorization expansion adds documentation work to both sides of the supplier-prescriber relationship. Practices that build templated documentation and respond quickly to requests speed patient access and prevent denials. Practices that handle DMEPOS prior auth as occasional paperwork end up explaining to patients why their equipment did not arrive on time.
Authoritative sources
This article cites the following primary sources for billing-code and regulatory guidance. Always confirm current rules and codes with the publishing authority before applying to a specific claim.
